Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $35.7900 (-0.56%) ($34.4300 - $36.1500) on Tue. Mar. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.68% (three month average) | RSI | 88 | Latest Price | $35.7900(-0.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2.6% a day on average for past five trading days. | Weekly Trend | IOVA advances 21.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) ARKG(48%) XBI(48%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -2.34% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.34% (StdDev 4.68%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
5 Day Moving Average | $34.27(4.44%) | 10 Day Moving Average | $30.59(17%) | 20 Day Moving Average | $27.2(31.58%) | To recent high | -0.6% | To recent low | 65.4% | Market Cap | $5.241b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |